Inspired by the desire to help our customers design a robust, reproducible, and scalable process beyond roller bottles and flatware, Pall Biotech and Polyplus‐transfection♦ scientists teamed up to propose a general guidance to:
- Scale-up viral vector production in the iCELLis® bioreactor systems with the transient transfection reagent, PEIpro♦
- Assist you during development to ensure your process is scalable and optimized to achieve the highest viral yield and recovery.
The iCELLis bioreactor family currently consists of two models. The iCELLis Nano bioreactor is a benchtop unit used for process development and clinical production of virus at small scale. When larger scales are required, processes developed in the iCELLis Nano bioreactor can be easily scaled up to the iCELLis 500+ bioreactor, the manufacturing-scale model.
For more information about the iCELLis bioreactor and transfection with PEIpro, download the guide today!
© 2021 Pall Corporation. Pall the Pall logo and iCELLis are trademarks of Pall Corporation. ♦PEIpro and Polyplus-transfection are trademarks of Polyplus-transfection. ® indicates a trademark registered in the USA
Fill out the form to download the guide
All fields required